Bank of America Corporation 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:23 am Purchase |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
BANK OF AMERICA CORP BAC |
3,276,699 6.300% |
3,276,699 (New Position) |
Filing |